> but we are struggling to turn these drugs into treatments that up to modern standards.

We are struggling to pay for the research that would result in these being effective treatments (not subscription medicines) that would start out as generic drugs.

> ketamine

Great example, SPRAVATO, is a brand name patent protected version of this drug (enantiomer) that as a dose cost over 500 bucks.